Homepage > Company > Media > Blog > 2021 > CHEMDIV AT THE INTERNATIONAL SYMPOSIUM ON MEDICINAL CHEMISTRY

CHEMDIV AT THE INTERNATIONAL SYMPOSIUM ON MEDICINAL CHEMISTRY

CHEMDIV-AT-THE-XXVI-EFMC-INTERNATIONAL-SYMPOSIUM-ON-MEDICINAL-CHEMISTRY-EFMC-ISMC-2021

The XXVI EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2021) will be held virtually, from August 29 to September 2, 2021.

We present the following poster: BEYOND BINARY SCALED MOLECULAR FINGERPRINTS FOR MAXIMUM DIVERSITY PICKING

Do not miss the opportunity to check out our virtual stand for our latest scientific results and to chat with our team during 2 sessions:

Poster Session 2
Tuesday, Aug 31 from 13:15 to 15:30 CEST

Poster Session 4
Thursday, Sept 2 from 13:15 to 15:30 CEST

Please register on https://www.efmc-ismc.org We look forward to welcoming you virtually!

Read also

CHEMDIV IS NOW A DISCOVERY PARTNER WITH GWYNANT THERAPEUTICS AND CELYN THERAPEUTICS

ChemDiv has been selected as a discovery partner with Gwynant Therapeutics and Celyn Therapeutics and starts to work on novel small molecules for oncology targets.

Our covalent compound library is now available in a ready-to-dock format for BioSolveIT

ChemDiv,Inc.

Science & Nature reviews, August 2021 (2)

These are ChemDiv's reviews on Nature and Science Journal articles.

OCULAR DISEASES SMALL MOLECULES LIBRARY

ChemDiv presets a brand new OCULAR DISEASES SMALL MOLECULES LIBRARY (13,000 compounds, 7 targets, 4 diseases)For design of screening library we use emerging Targets.